Insider · CIK 0001717503
Brightstar Associates LLC
Files at DCPH (Deciphera Pharmaceuticals, Inc.). First filing Jan 24, 2023, latest Jan 24, 2023.
In brief
Brightstar Associates LLC files SEC Form 4 as 10% owner at DCPH (Deciphera Pharmaceuticals, Inc.). Since Jan 24, 2023, Brightstar Associates LLC has reported 1 open-market buy worth $30M and 0 open-market sells worth $0, the latest filed on Jan 24, 2023.
A track record needs three past buys with six months of prices behind them; Brightstar Associates LLC has 0, so none is measured yet.
The newest scored trade: bought $30M of DCPH on Jan 24, 2023, filed Jan 24, 2023, scored 35 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | DCPHbuy Deciphera Pharmaceuticals, Inc. | $30M 1,666,666 shares | +9% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | XIn-the-money exercise Common Stock | +48,136 | $0.01 | $481 | 23,107,844 | Apr 24, 2024 |
| Apr 22, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | XIn-the-money exercise Warrants (right to buy)derivative | -48,136 | $0.00 | $0 | 0 | Apr 24, 2024 |
| Feb 7, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | XIn-the-money exercise Common Stock | +914,001 | $0.01 | $9,140 | 23,059,708 | Feb 9, 2024 |
| Feb 7, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | XIn-the-money exercise Warrants (right to buy)derivative | -914,001 | $0.00 | $0 | 48,136 | Feb 9, 2024 |
| Feb 28, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | XIn-the-money exercise Common Stock | +2,427,693 | $0.01 | $24k | 22,145,707 | Mar 1, 2023 |
| Feb 28, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | XIn-the-money exercise Warrants (right to buy)derivative | -2,427,693 | $0.00 | $0 | 962,137 | Mar 1, 2023 |
| Jan 24, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +1,666,666 | $18.00 | $30M | 19,718,014 | Jan 24, 2023 |
Questions about Brightstar Associates LLC
Answered from the filings on this page, as of the latest one.
Is Brightstar Associates LLC buying or selling?
Not in the last 12 months. Brightstar Associates LLC's latest open-market trade on SEC Form 4 was bought $30M of DCPH on Jan 24, 2023.
How did Brightstar Associates LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brightstar Associates LLC has 0.
Where does Brightstar Associates LLC file Form 4?
Brightstar Associates LLC has filed Form 4 at DCPH (Deciphera Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.